Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study
Author:
Zhao LeiORCID,
Chang Nijia,
Shi Lei,
Li Fengyi,
Meng Fanglin,
Xie Xiaohui,
Xu Zhe,
Wang Fusheng
Subject
Multidisciplinary
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献